Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quadrivalent and Bivalent Human Papilloma Virus Vaccines in the Treatment of Common Recalcitrant Warts

NCT05383625 is registered in ClinicalTrials.gov with Zagazig University as lead sponsor.

NCT NCT05383625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05383625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quadrivalent and Bivalent Human Papilloma Virus Vaccines in the Treatment of Common Recalcitrant Warts
Lead sponsor
Zagazig University
Phase
Phase 3
Overall status
Completed
Start date
September 1, 2020
Completion date
December 1, 2021
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

verruca viral